Reuse prevention syringes for reconstitution of lyophilized vaccines operational study and unicef plans for expanding introduction

International Journal of Occupational and Environmental Health

Volumn 15, Issue 1, 2009, Pages 9-13

  Fleming, Jessica A ^a   Hoekstra, Edward John ^b   Moniaga, Vanda ^b   Widjaya, Anton ^b   Soepardi, Jane ^d   Supartha, Nyoman ^d   Salovaara, Annika ^c   Khamassi, Selma ^e   Nelson, Carib ^a  

^a PATH   (United States)

^b United Nation's Children's Fund ^*

^c UNICEF   (United States)

^d Sub Directorate of Filariasis and Helminthiasis Control Directorate of Vector Borne Disease Control Indonesia Ministry of Health   (Indonesia)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

AD syringe; Autodisable syringe; Developing countries; Immunization programs; Indonesia; Injection safety; Reconstitution syringe; Reuse prevention syringe; Vaccine reconstitution

Indexed keywords

VACCINE;

ARTICLE; DISPOSABLE EQUIPMENT; FREEZE DRYING; HUMAN; IMMUNIZATION; INJECTION; INSTRUMENTATION; METHODOLOGY; PREVENTIVE HEALTH SERVICE; RECYCLING; SAFETY; STANDARD; SYRINGE; UNITED NATIONS;

DISPOSABLE EQUIPMENT; EQUIPMENT REUSE; FREEZE DRYING; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INJECTIONS; SAFETY MANAGEMENT; SYRINGES; UNITED NATIONS; VACCINES;

EID: 65249168176     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2009.15.1.9     Document Type: Article

References (27)

1. The United Nation's Children's Fund (UNICEF). Supply Annual Report 2007. Denmark: UNICEF Supply Division; 2008.
2. Hersh BS, Carr RM, Fitzner J, et al. Ensuring injection safety during measles immunization campaigns: More than auto-disable syringes and safety boxes. J Infect Dis. 2003. May 15;187 Suppl 1:S299-306.
3. Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of blood-borne pathogens. Bull World Health Organ. 1999;77(10):789-800.
4. Drucker E, Alcabes PG, Marx PA. The injection century: Massive unsterile injections and the emergence of human pathogens. Lancet. 2001. Dec 8;358(9297):1989-92.
5. Reeler AV. Injections: A fatal attraction? Soc Sci Med. 1990;31(10):1119-25.
6. Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology. 1999. Sep;10(5):594-605.
7. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004. Mar;19(1):95-103.
8. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003. Nov 8;327(7423):1075.
9. Hutin YJ, Harpaz R, Drobeniuc J, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol. 1999;28:782-86.
10. Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad.,Pakistan. Epidemiol Infect. 1997. Dec;119(3):349-56.
11. Hersh BS, Popovici F, Jezek Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993. Dec;7(12):1617-24.
12. Abulrahi HA, Bohlega EA, Fontaine RE, et al. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet. 1997. Jan 4;349(9044):23-5.
13. Ebola haemorrhagic fever in Zaire. 1976. Bull World Health Organ. 1978;56(2):271-93.
14. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. BMJ. 1995. Sep 30;311:857-59.
15. Soeters R, Aus C. Hazards of injectable therapy. Trop Doct. 1989. Jul;19(3):124-6.
16. Archibald LK, Ramos M, Arduino MJ, et al. Enterobacter cloacae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial. J Pediatr. 1998. Nov;133(5):640-4.
17. Safety of Injections: WHO-UNICEF-UNFP A joint statement on the use of auto-disable syringes in immunization services. Geneva (Switzerland): World Health Organization; 2003.
18. UNICEF Supply Division's unpublished data. 2008.
19. Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol. 2007. Jul;137 Suppl 1:S46-50.
20. Sood DK, Kumar S, Singh S, Sokhey J. Adverse reactions after measles vaccination in India. Natl Med J India. 1995. Sep-Oct;8(5):208-10.
21. Abdul Mujeeb S, Adil MM, Altaf A, et al. Recycling of injection equipment in Pakistan. Infect Control Hosp Epidemiol. 2003. Feb;24(2):145-6.
22. Hutin Y, Hauri A, Chiarello L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003;81(7):491-500.
23. Kidd-Lunggren K, Broman E, Ekvall H, Gustavson O. Nosocomial transmission of hepatitis B virus infection through multiple-dose vials. J Hosp Infect. 1999. Sep;43(1):57-62.
24. UNICEF. Programme Instruction: Introduction of 2, 5, and 10 ml re-use prevention featured (RPF) Syringes for the Reconstitution of Vaccines to Increase Injection Safety. New York: UNICEF; 2006.
25. PATH's unpublished data. 2003.
26. UNICEF, World Health Organization. Immunization Summary 2006: A statistical reference. New York: UNICEF; 2008.
27. E Hoekstra, A Salovaara. Further Access to Injection Safety by Introducing Re-use Prevention Featured (RPF) Syringes for Reconstitution of Vaccines. Proceedings of Global Injection Safety and Infection Control Meeting. 2007. Oct 23-25; Geneva, Switzerland.